IMMG — Immage Biotherapeutics Cashflow Statement
0.000.00%
Basic MaterialsHighly SpeculativeMicro Cap
Annual cashflow statement for Immage Biotherapeutics, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2012 September 30th | 2013 September 30th | 2014 September 30th | 2015 August 31st | 2016 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 11 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.002 | -0.012 | -0.019 | -0.054 | -0.216 |
Depreciation | |||||
Amortisation | |||||
Changes in Working Capital | 0.001 | 0 | 0.001 | 0.001 | -0.008 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -0.001 | -0.012 | -0.018 | -0.052 | -0.216 |
Capital Expenditures | — | — | — | -0.041 | 0 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | — | — | — | -0.041 | 0 |
Financing Cash Flow Items | -0.005 | 0.005 | 0 | 0 | -0.006 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.006 | 0.014 | 0.013 | 0.124 | 0.38 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.005 | 0.002 | -0.005 | 0.03 | 0.164 |